Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
A homogeneous substrate-labeled fluorescent immunoassay was developed for the measurement of kanamycin concentrations in serum. A fluorogenic drug reagent (FDR) (beta-galactosyl-umbelliferone-tobramycin) was prepared that is nonfluorescent under the conditions of the assay but is hydrolyzed upon cat...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180483/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3524437/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.6.961 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|